True Rx Insights

Health care spending is projected to rise 8% in 2025, driven by increased use of GLP-1 drugs for diabetes and obesity.

Patient-centered diabetes program drives significant A1C reduction in just 6 months.

PBMs inflate drug costs using spread pricing, hidden fees, and high-cost formularies; employers should seek transparent contracts for fair pricing.

Innovative tactics to help employers contain costs

Explore the costs of obesity and health benefit options

Definitions that Explain How Your Benefits Work

Knowledge to Make Informed Benefit Choice

Are Other GLP-1 Uses on the Horizon?

Smart Ways to Lower Health Costs

1,660 covered lives on the plan

6,400 covered lives on the plan

1,700 covered lives on the plan

How do you offer the care employees need while controlling skyrocketing costs? The good news? It can be done.

Mark Williams and Mark Cuban made the decision to start businesses that promote transparent pricing models that put patient care first.

Learn how to navigate a future of escalating prescription drug costs while still elevating employee health.

How a pharmacogenomics program utilizes gene-based science to guarantee the most effective drug therapies.

Learn how you can be proactive with diabetes management.

We discuss employer health care spend, work absenteeism, and treating obesity with patient care.

Discover benefits and trade-offs of covering GLP-1 drugs for weight loss and smart strategies for diabetes management.

Get PBM selection guidance in this one-hour webinar

Expand your knowledge of pharmacy benefits management terms.

An Educational Resource from True Rx Health Strategists

A Point of View Resource from True Rx Health Strategists

A Guide to Weight Loss Medications for Benefits Brokers and Advisors

Solutions to orphan drug management

Avoid cost pitfalls and maintain quality treatment.